The U.S. Food and Drug Administration is recalling more than 89,000 bottles of nasal spray because they might cause "adverse" ...
The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.